title: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations.
authors.forename: Neil F
authors.initials: NF
authors.lastname: Goodman
authors.forename: Rhoda H
authors.initials: RH
authors.lastname: Cobin
authors.forename: Samara Beth
authors.initials: SB
authors.lastname: Ginzburg
authors.forename: Ira A
authors.initials: IA
authors.lastname: Katz
authors.forename: Dwain E
authors.initials: DE
authors.lastname: Woode
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000517:prevention & control; D000075202:Contraindications; D016889:Endometrial Neoplasms / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods; D019317:Evidence-Based Medicine; D005260:Female; D006293:Health Promotion; D006801:Humans; D008403:Mass Screening; D008593:Menopause; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D047648:Perimenopause; D048789:Phytoestrogens / Q000009:adverse effects / Q000627:therapeutic use; D057285:Precision Medicine; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011788:Quality of Life; D018570:Risk Assessment; D016540:Smoking Cessation
chemical_list: D050071:Bone Density Conservation Agents; D048789:Phytoestrogens; D011372:Progestins